Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0000950123-09-026938
Filing Date
2009-07-29
Accepted
2009-07-29 15:52:25
Documents
8

Document Format Files

Seq Description Document Type Size
1 CUMBERLAND PHARMACEUTICALS, INC. - FORM S-1/A c0628620sv1za.htm S-1/A 2185515
2 EX-10.16 c0628620exv10w16.htm EX-10.16 254702
3 EX-23.1 CONSENT OF KPMG LLP. c0628620exv23w1.htm EX-23.1 2727
4 GRAPHIC c0628620c0628602.gif GRAPHIC 3768
5 GRAPHIC c0628620c0628643.gif GRAPHIC 6950
6 GRAPHIC c0628620c0628644.gif GRAPHIC 6473
7 GRAPHIC c0628620c0628645.gif GRAPHIC 8587
8 GRAPHIC c0628620c0628610.gif GRAPHIC 337
  Complete submission text file 0000950123-09-026938.txt   2481052
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: S-1/A | Act: 33 | File No.: 333-142535 | Film No.: 09970217
SIC: 2834 Pharmaceutical Preparations